Stephen Thomas's Insider Trades & SAST Disclosures
Stephen Thomas's most recent trade in Climb Bio Inc. was a trade of 25,093 Common Stock done . Disclosure was reported to the exchange on March 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen Thomas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc. | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 25,093 | 179,188 | - | - | Common Stock | |
| Climb Bio Inc. | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 25,093 | 25,094 | - | - | Restricted Stock Units | |
| Climb Bio Inc. | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 50,188 | 154,095 | - | - | Common Stock | |
| Climb Bio Inc. | Stephen Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 50,188 | 50,187 | - | - | Restricted Stock Units | |
| Climb Bio Inc. | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 103,907 | 103,907 | - | - | Common Stock | |
| Climb Bio Inc. | Stephen Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 100,375 | 100,375 | - | - | Restricted Stock Units | |
| Gamida Cell Ltd | Thomas Wills Stephen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 256,177 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 56,600 | 56,600 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 41,977 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 28,300 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 14,200 | 56,177 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 9,500 | 9,500 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 2,000 | 13,677 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Stephen Thomas Wills | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 Sep 2022 | 9,677 | 11,677 | - | 1.5 | 14,999 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges